Liyun Yuan

Assistant Professor of Clinical Medicine

University of Southern California

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Liyun Yuan is an Assistant Professor of Clinical Medicine at the University of Southern California. His research focuses on liver diseases, transplantation, metabolic risk factors, and disparities in healthcare, as evidenced by his recent articles. Dr. Yuan's work addresses critical issues such as liver transplantation for nonalcoholic steatohepatitis and the impact of metabolic disorders on liver health. He is dedicated to advancing the understanding of these complex medical challenges within diverse patient populations.

Articles (13)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (1)

Kali Zhou

Assistant Professor

University of Southern California

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Liyun Yuan

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

The impact of surging transplantation of alcohol-associated liver disease on transplantation for HCC and other indications

The Association of Metabolic Risk Factors with Advanced Adenomas in Hispanic Patients

Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study

Nutrition assessment and MASH severity in children using the Healthy Eating Index

Adult-Onset Still's Disease With Macrophage Activation Syndrome During Pregnancy: A Unique Cause of Hepatic Dysfunction.

Portrait of Regional Trends in Liver Transplantation for Nonalcoholic Steatohepatitis in the United States.

Nonalcoholic Fatty Liver Disease: The Role of Visceral Adipose Tissue.

Racial disparities in bariatric surgery postoperative weight loss and patient satisfaction.

Two Faces of Pioglitazone: Sorting Out the Roles of its PPARγ Binding Versus Mitochondrial Pyruvate Carrier Inhibition Is Not So Simple.

No Foul Play for Transjugular Intrahepatic Portosystemic Shunts in Liver Transplantation for Hepatocellular Carcinoma.

Metabolic Risk Profiles for Hepatic Steatosis Differ by Race/Ethnicity: An Elastography-Based Study of US Adults.

Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures.

PNPLA3 and nonalcoholic fatty liver disease: towards personalized medicine for fatty liver.

Collaborators (1)

Kali Zhou

Make your next move.